Article in Genes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
César M Cerecedo-ZapataLaboratory of Genomic Medicine, Department of Genetics, National Rehabilitation Institute (INR-LGII), Mexico City 14389, Mexico.ORCID 0009-0005-4413-3096
Araceli Guerra-GrajedaHospital Epidemiological Surveillance Unit, National Rehabilitation Institute (INR-LGII), Mexico City 14389, Mexico.
Luz C Márquez-QuirózLaboratory of Genomic Medicine, Department of Genetics, National Rehabilitation Institute (INR-LGII), Mexico City 14389, Mexico.
Paola Arciga-PortelaDepartment of Bioengineering, School of Engineering and Sciences, Tecnologico de Monterrey, Campus Ciudad de México, Mexico City 14380, Mexico.
Rosa E Escobar-CedilloDepartment of Muscular Dystrophy and Electrophysiology, National Rehabilitation Institute (INR-LGII), Mexico City 14389, Mexico.ORCID 0000-0002-5252-3140
Guadalupe E Jiménez-GutiérrezLaboratory of Genomic Medicine, Department of Genetics, National Rehabilitation Institute (INR-LGII), Mexico City 14389, Mexico.ORCID 0000-0003-0301-9121
Óscar A Pérez-MéndezDepartment of Bioengineering, School of Engineering and Sciences, Tecnologico de Monterrey, Campus Ciudad de México, Mexico City 14380, Mexico.ORCID 0000-0002-6977-1829
Jorge S Velasco-FloresLaboratory of Genomic Medicine, Department of Genetics, National Rehabilitation Institute (INR-LGII), Mexico City 14389, Mexico.
Blanca A Barredo-PrietoLaboratory of Genomic Medicine, Department of Genetics, National Rehabilitation Institute (INR-LGII), Mexico City 14389, Mexico.
Norberto Leyva-GarcíaLaboratory of Genomic Medicine, Department of Genetics, National Rehabilitation Institute (INR-LGII), Mexico City 14389, Mexico.ORCID 0000-0002-1665-8873
Bulmaro CisnerosDepartment of Genetics and Molecular Biology, Center of Research and Advanced Studies-National Polytechnic Institute (CINVESTAV-IPN), Mexico City 07360, Mexico.ORCID 0000-0003-2802-1201
Nadia M Murillo-MeloLaboratory of Genomic Medicine, Department of Genetics, National Rehabilitation Institute (INR-LGII), Mexico City 14389, Mexico.ORCID 0009-0006-1142-7917
Jonathan J MagañaLaboratory of Genomic Medicine, Department of Genetics, National Rehabilitation Institute (INR-LGII), Mexico City 14389, Mexico.ORCID 0000-0003-4399-4618
Funding
Instituto de Ciencia y Tecnologia del Distrito Federal PIFUTP08-164Secretaría de Ciencia, Humanidades, Tecnología e Innovación CB-2015-01-258043
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Fifteen Years of Myotonic Dystrophy Type 1 in Mexico: Clinical, Molecular, and Socioeconomic Insights from a National Reference Cohort. · full record | OpenQuestion